抗-NEXN 兔抗，100UL，HPA011185-100UL，Sigma

General description

NEXN (nexilin) is an F-actin binding protein, which is muscle-specific. It resides in adherens junctions. It is predominantly expressed in heart and skeletal muscles. This gene maps to human chromosome 1p31-1p32.

Immunogen

Nexilin recombinant protein epitope signature tag (PrEST)

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

Biochem/physiol Actions

NEXN (nexilin) is responsible for the stabilization of Z-disc and force generation in heart. In smooth muscle cells, its expression is suppressed in response to inflammatory cytokines. It protects vascular smooth muscle cells in injured vessels, by promoting contractility. Variations in this gene are associated with coronary artery diseases in humans. It is a part of focal adhesions, and is thought to play a role in actin-related motility. It is a part of the actin-rich structure of Listeria monocytogenes and enteropathogenic Escherichia coli, and is essential for their invasiveness and infection. Mutations in this gene are also responsible for hypertrophic cardiomyopathy (HCM), which is an inherited disorder characterized by cardiomyocyte hypertrophy, increase in fibrosis of myocardium and increased wall thickness of ventricles. NEXN might also be involved in the formation of stress fibers and focal adhesions, as well as form a part of focal adhesion signaling.

Features and Benefits

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Physical form

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Other Notes

Corresponding Antigen APREST72487

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.